Page last updated: 2024-10-26

diclofenac and Central Diabetes Insipidus

diclofenac has been researched along with Central Diabetes Insipidus in 1 studies

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Research Excerpts

ExcerptRelevanceReference
" The results indicated uniform trend to an increase in the number of clathrincoated vesicles under conditions of hormone treatment combined with prostaglandin synthesis blockade in animals with different neurohypophyseal status."1.43Electron Microscopic Study of the Inner Medulla in Rat Kidneys under Conditions of Vasopressin Treatment Combined with Prostaglandin Synthesis Blockade. ( Babina, AV; Lavrinenko, VA, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Babina, AV1
Lavrinenko, VA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium[NCT05188131]Phase 412 participants (Actual)Interventional2021-10-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for diclofenac and Central Diabetes Insipidus

ArticleYear
Electron Microscopic Study of the Inner Medulla in Rat Kidneys under Conditions of Vasopressin Treatment Combined with Prostaglandin Synthesis Blockade.
    Bulletin of experimental biology and medicine, 2016, Volume: 161, Issue:6

    Topics: Animals; Antidiuretic Agents; Aquaporins; Biological Transport; Clathrin-Coated Vesicles; Diabetes I

2016